Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2008
02/07/2008WO2008016314A1 Myostatin antagonists
02/07/2008WO2008016221A1 Cysteine-tagged staphylococcal protein g variant
02/07/2008WO2008016155A1 Method for screening for vitamin d receptor ligand
02/07/2008WO2008016141A1 Kif-derived peptide capable of binding to hla-a24 molecule
02/07/2008WO2008016133A1 Drug-phosphorylating enzyme
02/07/2008WO2008015975A1 Method for amplification of dna fragment
02/07/2008WO2008015942A1 Therapeutic agent for neuroblastoma, method for screening for the therapeutic agent, and method for determination of prognosis of neuroblastoma
02/07/2008WO2008015884A1 Method for obtaining oligonucleotide
02/07/2008WO2008015861A1 Method for designing mutated enzyme, method for preparing the same and mutated enzyme
02/07/2008WO2008015841A1 Kinase-inhibiting fused protein and pharmaceutical composition
02/07/2008WO2008015662A1 A method of producing recombinant biological products
02/07/2008WO2008015577A2 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
02/07/2008WO2008015524A2 Peptide deformylase as a tool for development of mycobacteria specific antisense nucleic acid molecules
02/07/2008WO2008015447A2 Enhanced expression method
02/07/2008WO2008015425A2 Mhc oligomers, components thereof, and methods of making the same
02/07/2008WO2008015383A2 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies
02/07/2008WO2008015263A2 Plants having improved characteristics and a method for making the same
02/07/2008WO2008015239A2 Muteins of tear lipocalin and methods for obtaining the same
02/07/2008WO2008015199A1 Chemokine antagonists
02/07/2008WO2008015028A1 Uses and compositions comprising mirnas
02/07/2008WO2008014979A2 NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
02/07/2008WO2008014668A1 Attenuated salmonella carrying effective plasmid and its antitumorigenic use
02/07/2008WO2008014612A1 Fusion proteins and methods for modulation of immune response
02/07/2008WO2008014603A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
02/07/2008WO2008014574A1 Cleavage of bip by subtilase cytotoxin
02/07/2008WO2008014550A1 Markers for pigmentation
02/07/2008WO2008014547A1 Cells genetically modified to express markers of fenestration and uses thereof
02/07/2008WO2007148971A3 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
02/07/2008WO2007145523A3 Synthesis of lewis x epitopes on proteins in plants
02/07/2008WO2007143245A3 An l-arabinose fermenting yeast
02/07/2008WO2007143086A3 Delivery method
02/07/2008WO2007138455A3 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2
02/07/2008WO2007138261A3 Modified sugar nucleotide
02/07/2008WO2007138043A3 Sirna kinase and methods of use
02/07/2008WO2007092465A3 Topical delivery compositions
02/07/2008WO2007067516A3 Multiple myeloma
02/07/2008WO2007053655A3 Cell-free synthesis of membrane bound polypeptides
02/07/2008US20080034456 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
02/07/2008US20080034455 Production Of A Protein Localized To The Endoplasmic Reticulum Protein Bodies In A Transgenic Plant And Seed
02/07/2008US20080034452 Method for increasing resistance of monocot plants against abiotic stresses, tps plant gene constructs, and transformants
02/07/2008US20080034451 Rice Pollen-Preferential Promoters And Uses Thereof
02/07/2008US20080034449 DNA encoding ring zinc-finger protein and the use of the DNA in vectors and bacteria and in plants
02/07/2008US20080033061 Cation conducting gabaa receptors and their use
02/07/2008US20080032961 Therapy employing LXRalpha modolators
02/07/2008US20080032947 Pka ligands and polynucleotides encoding pka ligands
02/07/2008US20080032945 2'-modified oligonucleotides
02/07/2008US20080032944 Target Nucleic Acid Of Retrovirus Integration
02/07/2008US20080032942 double-stranded (siNA) molecule that down-regulates expression of a beta-secretase (BACE) gene
02/07/2008US20080032941 Method for rendering a system immunologically compatible utilizing a nucleic acid construct, a nucleic acid construct for inhibiting or regulating the function of an immune response (Ir) gene and an immunologically compatible system containing a nucleic acid construct for inhibiting or regulating the function of an immune response (Ir) gene
02/07/2008US20080032927 Treatment of development-related disorders
02/07/2008US20080032926 Knockout Non-Human Animal
02/07/2008US20080032924 Antifungal Peptides
02/07/2008US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression
02/07/2008US20080032921 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
02/07/2008US20080032919 BMP-7 Variant Compositions, Methods and Uses
02/07/2008US20080032896 Methods for identifying compounds that bind to a target
02/07/2008US20080032404 Method for constructing eukaryotic cells having multiple genomic deletions and/or insertions
02/07/2008US20080032400 elastin-like peptides (ELP) spider structure complex including multi-leg moieties comprising ELP fusion proteins capable of forming covalent disulfide bonds; employed in peptide production and purification and/or to enhance protelytic resistance of a protein or peptide moiety in a fusion construct
02/07/2008US20080032399 Method and kits for preparing multicomponent nucleic acid constructs
02/07/2008US20080032387 Propagating thraustochytriales and using as bioreactors for fermentation of polyunsaturated fatty acids
02/07/2008US20080032386 Stabilized Proline Transporter
02/07/2008US20080032385 Novel antimicrobial peptide isolated from Penaeus monodon
02/07/2008US20080032381 Propagating thraustochytriales and using as bioreactors for fermentation of polyunsaturated fatty acids
02/07/2008US20080032378 have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or high-glucose syrup or a mixed syrup, and for liquifying a starch-comprising composition
02/07/2008US20080032370 Process for Producng Hydroxycarboxylic Acid
02/07/2008US20080032369 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms ; plants and microorganisms that produce lipids
02/07/2008US20080032368 Pufa polyketide synthase systems and uses thereof
02/07/2008US20080032367 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms; plants and microorganisms that produce lipids
02/07/2008US20080032366 Enhanced Production of Lipids Containing Polyenoic Fatty Acid by Very High Density Cultures of Eukaryotic Microbes in Fermentors
02/07/2008US20080032365 Enhanced Production of Lipids Containing Polyenoic Fatty Acid by Very High Density Cultures of Eukaryotic Microbes in Fermentors
02/07/2008US20080032364 Enhanced Production of Lipids Containing Polyenoic Fatty Acid by Very High Density Cultures of Eukaryotic Microbes in Fermentors
02/07/2008US20080032363 Enhanced Production of Lipids Containing Polyenoic Fatty Acid by Very High Density Cultures of Eukaryotic Microbes in Fermentors
02/07/2008US20080032362 Enhanced Production of Lipids Containing Polyenoic Fatty Acid by Very High Density Cultures of Eukaryotic Microbes in Fermentors
02/07/2008US20080032361 Enhanced Production of Lipids Containing Polyenoic Fatty Acid by Very High Density Cultures of Eukaryotic Microbes in Fermentors
02/07/2008US20080032360 Enhanced Production of Lipids Containing Polyenoic Fatty Acid by Very High Density Cultures of Eukaryotic Microbes in Fermentors
02/07/2008US20080032351 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest
02/07/2008US20080032346 Method of increasing complementarity in a heteroduplex
02/07/2008US20080032345 Method and Tools for Analysis of Nucleic Acids
02/07/2008US20080032342 Chimeric immunogens
02/07/2008US20080032340 Peptide motifs for binding avidin or neutravidin
02/07/2008US20080032338 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest
02/07/2008US20080032337 Genetic engineering; analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases
02/07/2008US20080032336 Chemokine receptor materials and methods
02/07/2008US20080032335 Provides polypeptide having wide substrate specificity and having omega 3 fatty acid desaturation activity, which makes efficiently unsaturated bond at omega 3 position, and a polynucleotide coding for the same; by expressing the polypeptide in the organism, mass production of n-3 series PUFAs is enabled
02/07/2008US20080032333 Polynucleotides encoding soluble zalpha11 cytokine receptors
02/07/2008US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders
02/07/2008US20080032323 Nucleic Acid Construct Containing a Nucleic Acid Derived From the Genome of Hepatitis C Virus (Hcv) of Genotype 2A, and a Cell Having Such Nucleic Acid Construct Introduced Therein
02/07/2008US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor
02/07/2008US20080032314 Use of VEGF and homologuest to treat neuron disorders
02/07/2008US20080032308 Isolating, positioning, and sequencing single molecules
02/07/2008US20080032304 FULL-LENGTH cDNA AND POLYPEPTIDES
02/07/2008US20080032303 Species identification by melting analysis of secondary structure of single stranded nucleic acids
02/07/2008US20080032302 Method and Probe Set for Detecting Cancer
02/07/2008US20080032300 Lupac Bifunctional Marker and Its Use in Protein Production
02/07/2008US20080032296 Sequences with FabA-like beta -hydroxyacyl-ACP dehydrase (DH) activity; biosynthesis of polyunsaturated fatty acids (PUFAs)
02/07/2008US20080032289 Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9, alpha2delta-4, 8099, 46455, 54414, 53763, 97076, 97102, 44181, 67084Fl and 67084alt molecules and uses therefor
02/07/2008US20080032279 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
02/07/2008US20080032024 Maltogenic Alpha-Amylase Variants
02/07/2008US20080031952 Nucleic Acid Comprising a Sequence Encoding a Modified Glutenin Polypeptide
02/07/2008US20080031936 Immunostimulatory nucleic acid molecules
1 ... 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 ... 4023